cycloheximide has been researched along with Parkinson Disease, Secondary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Itano, Y; Kitamura, Y; Nomura, Y | 1 |
| Dostert, P; Kasamatsu, T; Maruyama, W; Naoi, M | 1 |
2 other study(ies) available for cycloheximide and Parkinson Disease, Secondary
| Article | Year |
|---|---|
1-Methyl-4-phenylpyridinium (MPP+)-induced cell death in PC12 cells: inhibitory effects of several drugs.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Aurintricarboxylic Acid; Bucladesine; Cycloheximide; L-Lactate Dehydrogenase; Nerve Growth Factors; Parkinson Disease, Secondary; PC12 Cells; Potassium; Rats | 1994 |
Oxidation of N-methyl(R)salsolinol: involvement to neurotoxicity and neuroprotection by endogenous catechol isoquinolines.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antioxidants; Corpus Striatum; Cycloheximide; Disease Models, Animal; DNA Damage; Dopamine; Homovanillic Acid; Humans; Hydroxyl Radical; Isoquinolines; Male; Necrosis; Neuroblastoma; Neurons; Neurotoxins; Oxidative Stress; Parkinson Disease, Secondary; Posture; Rats; Rats, Wistar; Salsoline Alkaloids; Stereoisomerism; Substantia Nigra; Tetrahydroisoquinolines; Tumor Cells, Cultured | 1998 |